Lindahl advises Corline Biomedical AB on directed share issue
Lindahl is acting as legal adviser to Corline Biomedical AB (publ) in connection with a directed share issue amounting to approximately SEK 23 million.
Through the share issue, Corline Biomedical will receive approximately SEK 23 million before deduction of issue costs. In addition, the company strengthens its shareholder base with a long-term and international investor, Eiffel Investment Group, to which the issue is directed.
Corline Biomedical develops and sells medical technology solutions. The company's shares are listed on Nasdaq First North Growth Market.
Lindahl's team consists of Mattias Prage and Olle Swärd Brattström.
Do you want to know more? Contact:
Mattias Prage
Partner | AdvokatOlle Swärd Brattström
AssociateCarousel items
-
Cases and transactions
2/24/2026
Lindahl advises Medivir in directed share issue of SEK 45 million
Lindahl has acted as legal adviser to Medivir AB (publ) in connection with the company's directed share issue of SEK 45 million to Carl Bennet AB. The issue was carried out at a premium of 19 per cent to the closing price and has been well receive...
-
Knowledge
2/20/2026
Ambiguities and contradictions in construction contracts
Lindahl's construction law webinar addressed the interpretation of unclear contractual provisions, ranking in the event of conflicting contract documents and adjustment of delay penalties. The article summarises practical advice and recent case la...
-
News articles
2/12/2026
Lindahl ranked in Chambers and Partners Global Guide 2026
Lindahl is proud to once again be ranked in Chambers and Partners Global Guide. This year's ranking confirms the firm's strong position within several business-critical practice areas.
-
Portraits
1/20/2026
How I use AI in my daily work as a lawyer
AI is no longer the future – it is everyday reality. Johanna Karlsson, lawyer and senior associate at Lindahl, talks about how AI tools such as Legora have become a natural part of her workflow.
-
Read more news and insights?